DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,427,277 | +104836.6% | 110,549 | +1.5% | 0.55% | +3.2% |
| Q2 2023 | $26,137 | -4.4% | 108,906 | +0.4% | 0.53% | -9.7% |
| Q1 2023 | $27,334 | -4.6% | 108,449 | +0.5% | 0.59% | -8.6% |
| Q4 2022 | $28,652 | -99.9% | 107,951 | +0.6% | 0.64% | -5.9% |
| Q3 2022 | $27,721,000 | +2.0% | 107,325 | +0.1% | 0.68% | +7.4% |
| Q2 2022 | $27,179,000 | -10.4% | 107,207 | +3.6% | 0.64% | +1.3% |
| Q1 2022 | $30,344,000 | -4.8% | 103,446 | +6.8% | 0.63% | -4.1% |
| Q4 2021 | $31,871,000 | -6.3% | 96,870 | -13.3% | 0.66% | -10.2% |
| Q3 2021 | $34,027,000 | +0.5% | 111,768 | -11.4% | 0.73% | -1.0% |
| Q2 2021 | $33,859,000 | +9.8% | 126,170 | -7.9% | 0.74% | +2.6% |
| Q1 2021 | $30,835,000 | +0.9% | 136,997 | -0.4% | 0.72% | -6.6% |
| Q4 2020 | $30,568,000 | +2.0% | 137,608 | -1.1% | 0.77% | -12.5% |
| Q3 2020 | $29,966,000 | +29.7% | 139,161 | +6.5% | 0.88% | +18.8% |
| Q2 2020 | $23,096,000 | +46.6% | 130,610 | +14.7% | 0.74% | +5.9% |
| Q1 2020 | $15,758,000 | -8.3% | 113,851 | +1.6% | 0.70% | +14.1% |
| Q4 2019 | $17,192,000 | +9.4% | 112,017 | +2.9% | 0.61% | -0.8% |
| Q3 2019 | $15,721,000 | +1.6% | 108,846 | +0.5% | 0.62% | -1.9% |
| Q2 2019 | $15,479,000 | +9.9% | 108,304 | +1.5% | 0.63% | +5.2% |
| Q1 2019 | $14,086,000 | +28.6% | 106,693 | +0.4% | 0.60% | +10.9% |
| Q4 2018 | $10,957,000 | -5.0% | 106,256 | +0.1% | 0.54% | +6.7% |
| Q3 2018 | $11,537,000 | +10.6% | 106,175 | +0.5% | 0.50% | +4.8% |
| Q2 2018 | $10,428,000 | +1.7% | 105,678 | +0.9% | 0.48% | -1.2% |
| Q1 2018 | $10,258,000 | +2.9% | 104,771 | -2.4% | 0.49% | +6.8% |
| Q4 2017 | $9,967,000 | +7.0% | 107,378 | -1.1% | 0.46% | +0.7% |
| Q3 2017 | $9,315,000 | +2.8% | 108,596 | +1.1% | 0.45% | +0.9% |
| Q2 2017 | $9,063,000 | -0.1% | 107,396 | +1.3% | 0.45% | -3.0% |
| Q1 2017 | $9,068,000 | +11.1% | 106,018 | +1.1% | 0.46% | +6.7% |
| Q4 2016 | $8,163,000 | -16.9% | 104,867 | +7.8% | 0.44% | -25.9% |
| Q2 2016 | $9,829,000 | +9.6% | 97,313 | +2.9% | 0.59% | +5.4% |
| Q1 2016 | $8,969,000 | +2.3% | 94,545 | +0.2% | 0.56% | -1.4% |
| Q4 2015 | $8,766,000 | +7.7% | 94,383 | -1.2% | 0.56% | +0.9% |
| Q3 2015 | $8,139,000 | +1.3% | 95,518 | +1.8% | 0.56% | +9.6% |
| Q2 2015 | $8,034,000 | -0.7% | 93,870 | -1.5% | 0.51% | +1.6% |
| Q1 2015 | $8,092,000 | -4.1% | 95,311 | -3.2% | 0.50% | -6.0% |
| Q4 2014 | $8,437,000 | +18.7% | 98,442 | +5.2% | 0.54% | +7.2% |
| Q3 2014 | $7,110,000 | +0.5% | 93,583 | +4.2% | 0.50% | +1.4% |
| Q2 2014 | $7,072,000 | +5.1% | 89,831 | +0.1% | 0.49% | +1.7% |
| Q1 2014 | $6,730,000 | -1.3% | 89,735 | +1.6% | 0.48% | -5.3% |
| Q4 2013 | $6,816,000 | +12.6% | 88,285 | +1.1% | 0.51% | +2.2% |
| Q3 2013 | $6,054,000 | +13.1% | 87,335 | +3.2% | 0.50% | +12.4% |
| Q2 2013 | $5,355,000 | – | 84,593 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |